Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Endocrinology Final > Endocrinology of Cancer > Flashcards

Endocrinology of Cancer Flashcards

1
Q

Carcinoma

A

Cancers arising from epithelial cells (line surfaces of organs, skin, and glands)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Sarcoma

A

Cancers arising from CT (bones, muscle, cartilage, fat)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Adenoma

A

Benign tumor originating from glandular tissue (adrenal gland or thyroid)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hyperplasia

A

Increase in the number of cells within a tissue or organ (can lead to enlargement)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Dysplasia

A

Abnormal development or growth of cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Anaplasia

A

Lack of differentiation in cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Angiogenesis

A

Formation of new blood vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Explain the causes and mechanisms of hypercalcemia of neoplasia.

A
  1. Humoral hypercalcemia of malignancy: tumor cells secrete PTHrp (mimics PTH)
  2. Osteolytic Hypercalcemia: tumor invasion of bone stimulates osteoclast activity -> localized bone resorption and calcium release
  3. Vitamin D-Mediated Hypercalcemia: tumor cells produce excess vitamin D3
  4. Ectopic PTH secretion (rate) tumors produce PTH
  5. Diagnosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which term describes a tumor that has not yet invaded surrounding tissues?
A. Dysplasia
B. In situ
C. Metastasis
D. Anaplasia

A

In situ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does carcinoma specifically refer to?
A. Cancers arising from CT
B. Benign tumor of glandular tissue
C. Cancers arising from epithelial cells
D. Tumor capable of metastasis

A

Cancers arising from epithelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which of the following processes allows tumors to obtain nutrients for growth by forming new blood vessels?
A. Anaplasia
B. Dysplasia
C. Hyperplasia
D. Angiogenesis

A

Angiogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

A tumor described as poorly differentiated on histology would most likely be classified as:
A. well-differentiated
B. low-grade
C. high-grade
D. non-invasive

A

High-grade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the main difference between a benign tumor and a malignant tumor?
A. Benign tumors arise only from epithelial cells
B. Malignant tumors invade and metastasize
C. Benign tumors always regress without treatment
D. Malignant tumors are always hormone-dependent

A

Malignant tumors invade and metastasize

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the most common mechanism of hypercalcemia in cancer patients?
A. Tumor production of PTH
B. Tumor secretion of PTH-related peptide (PTHrP)
C. Excess dietary calcium
D. Tumor suppression of calcitonin

A

Tumor secretion of PTHrP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

In humoral hypercalcemia of malignancy, PTH levels are typically:
A. Increased
B. Decreased
C. Normal
D. Unaffected

A

Decreased (because tumor cells secrete PTHrP -> negative feedback)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which hormone can be used for rapid but short-term reduction of hypercalcemia?
A. PTHrP
B. Calcitonin
C. Vitamin D
D. Cortisol

A

Calcitonin

16
Q

What should be measured in neoplasia?

A
  1. Serum calcium: elevated total calcium (bound to protein) or ionized calcium levels
  2. PTH: suppressed in msot cancer-associated hypercalcemia (when elevated PTHrP)
  3. PTHrP: elevated in humoral hypercalcemia of malignancy
  4. VitD3: elevated in vitamin D-mediated hypercalcemia
17
Q

How is neoplasia managed?

A
  • Focuses on lowering calcium levels and addressing underlying cancer
  • Calcitonin provides rapid but short-term reduction in calcium by inhibiting bone resorption
18
Q

Pituitary Adenoma

A
  • Benign growth in the pituitary gland, some can change H production/secretion
  • Dx/Rx: increase hormone -> result (-treatment)
  • Increase ACTH -> excess adrenal cortisol (- inhibit POMC breakdown)
  • Increase GH -> giantism (birth) acromegaly (adult onset) (-somatostatin)
  • Increase prolactin -> infertility, galactorrhea, amenorrhea (dopamine agonists)
19
Q

Adrenal Adenoma

A
  • Benign (Adrenal carcinoma: neoplastic) growth in the adrenal cortex or medulla, some can result in altered secretion of HPA hormones
  • Increased cortisol (decreased CRH, ACTH)
  • Increased aldosterone
  • Catecholamines (medulla)
20
Q

A pituitary adenoma producing excess ACTH would lead to which condition?
A. Increased cortisol from adrenal cortex
B. Increased catecholamines from adrenal medulla
C. Increased aldosterone from adrenal cortex
D. Increased cortisol from adrenal medulla

A

Increased cortisol from adrenal cortex

21
Q

Which hormone is likely elevated in an adrenal adenoma producing cortisol?
A. CRH
B. ACTH
C. Aldosterone
D. Cortisol

A

Cortisol (or aldosterone)

22
Q

What would CRH levels likely be in a patient with an adrenal cortisol-producing tumor?
A. Increased
B. Decreased
C. Normal
D. Fluctuating

A

Decreased

23
Q

What would the clinical sign of a benign adenoma from lactotroph cells?
A. Hypertension
B. Galactorrhea
C. Water retention
D. Giantism

A

Galactorrhea

24
Q

Benign prostatic hyperplasia

A
  • Benign enlargement of prostate gland due to hyperplasia of stromal and epithelial cells
  • Age associated (>50 years), increased DHT, and chronic inflammation
25
Q

Prostatic Cancer

A
  • Malignant growth of prostate cells, tumor capable of invasion and metastasis
  • Genetic mutations, family history, aging, and androgen signaling abnormalities
  • Radiation, chemo, decrease androgens
26
Q

Which feature distinguishes benign prostatic hyperplasia (BHP) from prostate cancer?
A. BHP is invasive and metastatic
B. Prostate cancer is associated with increased DHT
C. BPH affects stromal and epithelial cells but does not invade
D. Prostate cancer results from decreased androgen signaling

A

BPH affects stromal and epithelial cells, but does not invade

27
Q

What is a common treatment for BPH?
A. Estrogen therapy
B. 5-alpha reductase inhibitors
C. Aromatase inhibitors
D. Androgen receptor blockers

A

5- alpha reductase inhibitors (to decrease DHT synthesis)

28
Q

Estrogen receptor-positive (ER+) breast cancer is typically treated with:
A. Aromatase inhibitors and selective estrogen receptor modulators (SERMs)
B. Testosterone supplements and SERMs
C. Calcitonin and PTH analogs
D. Alpha adrenergic receptor blockers and calcitonin

A

Aromatase inhibitors and selective estrogen receptor modulators (SERMs)?

29
Q

Why does ER+ breast cancer have a better prognosis than ER- breast cancer?
A. ER+ tumors grow more rapidly, allowing for early detection
B. ER+ tumors respond well to therapy directed against ERs
C. ER+ tumors are not invasive or metastatic
D. ER+ tumors are more common in younger women

A

ER+ tumors respond well to therapy directed against ERs

Endocrinology Final (13 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions